Antineutrophil cytoplasm antibodies (ANCA): Description and immunopathological role;Les auto-anticorps < anti-cytoplasme des polynucleaires > (ANCA) : Description et role immunopathologique

Annales de Medecine Interne

Volumn 151, Issue 3, 2000, Pages 178-183

  Noël, Laure Hélène ^a  

^a HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

ANCA; Auto antibodies; Vasculitis

Indexed keywords

NEUTROPHIL CYTOPLASMIC ANTIBODY;

ANTIBODY SPECIFICITY; CLINICAL PRACTICE; HUMAN; IMMUNOPATHOLOGY; LEUKOCYTE ACTIVATION; REVIEW; SYSTEMIC VASCULITIS; AUTOIMMUNE DISEASE; BLOOD; IMMUNOLOGY; VASCULAR DISEASE;

ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; AUTOIMMUNE DISEASES; HUMANS; VASCULAR DISEASES;

EID: 0034182555     PISSN: 0003410X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (42)

1. VAN DER WOUDE FJ, RASMUSSEN N, LOBATTO S, WIIK A, PERMAN H, VAN ES LA, et al. Autoantibodies against neutrophils and monocytes tool for diagnosis and marker of disease activity in Wegener's granulomatosis. Lancet, 1985; 1: 425-9.
2. SAVAGE COS, WINEARLS CG, JONES S, MARSHALL PD, LOCKWOOD CM. Prospective study of radioimmunoassay for antibodies against neutrophil cytoplasm in diagnosis or systemic vasculitis. Lancet, 1987; 1; 1389-93.
3. FALK RJ, JENNETTE JC. Antineutrophil cytoplasmic autoantibodies with specificity for myeloperoxydase in patients with systemic vasculitis and idiopathic necrotizing and crescentic glomerulonephritis. N Engl J Med, 1988; 25: 1651-7.
4. HOFFMAN GS, SPECKS U. Antineutrophil cytoplasmic antibodies. Arthritis Rheum, 1998; 44: 1521-37.
5. WIIK A. Delineation of a standard procedure for indirect immunofluorescence detection of ANCA. APMIS, 1989; 97: 12-5.
6. BASLUND B, SEGELMARK M, WIIK A, SZPIRT W, PETERSEN J, WIESLANDER J. Screening for antineutrophil antibodies (ANCA): is indirect immunofluorescence the method of choice. Clin Exp Immunol, 1995; 99: 486-92.
7. LESAVRE P. Antineutrophil cytoplasmic autoantibodies : antigen specificity. Am J Kidney Dis, 1991; 18: 159-63.
8. COHEN-TERVAERT JW, GOLDSCHMEDING R, ELEMA JD, LIMBURG, PC, VAN DER GIESSEN M, HUITEMA MG, et al. Association of autoantibodies to myeloperoxydase with different form of vasculitis. Arthitis Rheum, 1990; 33: 1264-72.
9. VENNING MC, QUINN A, BROOMHEAD V, BIRD AG. Antibodies direct against neutrophils (c-ANCA and p-ANCA) are of distinct diagnostic value in systemic vasculitis. QJM, 1990; 77: 1287-96.
10. GASKIN G, SAVAGE COS, JONES RS, REES AJ, LOCKWOOD CM, PUSEY CD. Antibeutrophil cytoplasmic antibodies and disease activity during long-term follow up of 70 patients with systemic vasculitis. Nephrol Dial Transplant, 1991; 6: 689-94.
11. GEFFRIAUD-RICOUARD C, NOËL LH, CHAUVEAU D, HOUHOU S, GRÜNFELD JP, LESAVRE P. Clinical spectrum associated with ANCA of defined antigen specificities in 98 selected patients. Clin Nephrol, 1993; 39: 125-36.
12. GUILLEVIN L, VISSER H, NOËL LH, POURRAT J, VERNIER I, GAYRAUD M , et al. Antineutrophil cytoplasm antibodies in systemic polyarteritis nodosa with and without hepatitis B virus infection and Churg Strauss-62 patients. J Rheumatol, 1993; 20: 1345-9.
13. ZHAO MH, LOCKWOOD CM. A comprehensive method to purify three major ANCA antigens: proteinase 3, myeloperoxydase and bactericidal/permeability-increasing protein from human neutrophil granule acid extract. J Immunol Methods, 1996; 197: 121-30.
14. RONDA N, ESNAULT VLM, LAYWARD L, ALLEN VSA, FEEHALLY J, LOCKWOOD CM. Antineutrophil cytoplasm antibodies (ANCA) of IgA isotype in adult Henoch Schönlein purpura. Clin Exp Immunol, 1994; 95: 49-55.
15. GUZMAN J, FUNG M, PETTY RE. Diagnostic value of antineutrophil cytoplasmic and anti-endothelial cell antibodies in early Kawasaki disease. J Pediatr, 1994; 124: 917-20.
16. GARCIA-TORRES R, NOËL LH, REYES PA, VERA OL, AMIGO MC, SILVEIRA LH, PINEDA C. Absence of ANCA in Mexican patients with Takayasu's arteritis. Scand J Rheumatol 1997; 26: 55-7.
17. BEN HMIDA M, HACHICHA J, KADDOUR N, MAKNI H, AYDEL FZ, CHAKROUN N, et al. ANCA in Behcet's disease. Nephrol Dial Transplant 1997; 12: 2465-7.
18. AFELTRA A, SEBASTIAN GD, GALEAZZI M, CACCAVO D, FERRI GM, MARCOLONGO R, et al. Antineutrophil cytoplasmic antibodies in synovial fluid and in serum of patients with rheumatoid arthritis and other type of synovitis. J Rheumatol, 1996; 23: 10-5.
19. LOCKE IC, WORRAL JG, LEAKER B, BLACK CM, CAMBRIDGE G. Autoantibodies to myeloperoxydase in systemic sclerosis. J Rheumatol, 1997; 24: 86-9.
20. RUMP JA, SCHÖLMERICH J, GROSS V, ROTH M, HELFESRIEDER R, RAUTMAN A, et al. Anew type of perinuclear antineutrophil cytoplasmic antibody (p-ANCA) in active ulcerative colitis but not in Crohn's disease. Immunobiology, 1990; 181: 406-13.
21. HALBWACHS-MECARELLI L, NUSBAUM P, NOËL LH, REUMAUX D, ERLINGER S. Antineutrophil cytoplasmic antibodies (ANCA) directed against cathepsin G in ulcerative colitis, Crohn's disease and primary sclerosing cholangitis. Clin Exp Immunol, 1992; 90: 79-84.
22. STOFFEL MP, CSERNOK E, HERZBERG C, JOHNSTON T, CARROLL SF, GROSS WL. Anti-neutrophil cytoplasmic antibodies (ANCA) direct against bactericidal/permeability increasing protein (BPI): a new sero marker for inflammatory bowel disease and associated disorders. Clin Exp Immunol, 1996; 104: 54-9.
23. ABAD E, TURAL C, MIRAPEIX E, Cuxart A. Relationship between ANCA and disease activity in inflammatory bowel disease: variation in prevalence of ANCA and evidence of heterogeneity. J Autoimmun, 1997: 10: 175-80.
24. ZAULI D, GHETTI S, GRASSI A, DESCOVICH C, CASSANI F, BALLARDINI G, et al. Anti-neutrophil cytoplasmic antibodies in type 1 and 2 autoimmune hepatitis. Hepatology, 1997; 25: 1105-7.
25. SHORT AK, LOCKWOOD CM. Antigen specificity in hydralazine associated ANCA positive associated vasculitis. QJM, 1995; 88: 775-83.
26. EKKLAYAM O, YARON M, CASPI D. Minocycline induces arthritis associated with fever, livedo reticularis, and p-ANCA. Ann Rheum Dis, 1996; 55: 769-71.
27. VOGT BA, KIM Y, JENNETTE JC, FALK RJ, BURKE BA, SINAIKO A. Antineutrophil cytoplasmic auto-antibody-positive crescentic glomerulonephritis as a complication of treatment with propylthiouracil in children. J Pediatr, 1994; 124: 986-8.
28. SOTO A, JORGENSEN C, OKSMAN F, NOËL LH, Sany J. Endocarditis associated with ANCA. Clin Exp Rheumatol, 1994; 12: 203-4.
29. ZHAO MH, JAYNE DR, ARDILES LG, CULLEY F, HODSON ME, LOCKWOOD CM. Autoantibodies against bactericidal/permeability-increasing protein in patients with cystic fibrosis. QJM, 1996; 89: 259-65.
30. SAVIGE JA, CHANG L, HORN S, CROWE SM. Anti-nuclear, anti-neutrophil cytoplasmic and anti-glomerular basement membrane antibodies in HIV-infected individuals. Autoimmunity, 1994; 18: 205-11.
31. LESAVRE P, NOËL, LH, GAYNO S, NUSBAUMÙ P, REUMAUX D, ERLINGER S, et al. Atypical autoantigen targetts of perinuclear antineutrophil cytoplasm antibodies (p-ANCA). Specificity and clinical implication. J Autoinmmunity, 1993; 6: 185-95.
32. HAGEN EC, STEGMAN CA, D'AMARO J, et al. Decreased frequency of HLA-DR13, DR6 in Wegener's granulomatosis. Kidney Int, 1995; 48: 801-5.
33. RAO JY, WEINBERGER M, ODDONE EZ, ALLEN NB, LANDSMAN P, FEUSSNER JR. The role of antineutrophil cytoplasmic antibody (c-ANCA) testing in the diagnosis of Wegener's granulomatosis. Ann Intern Med, 1995; 123: 425-32.
34. MROWKA C, CSERNOK E, GROSS WL, FEUCHT HE, BECHTEL U, THOENES GH. Distribution of the granulocyte serine proteinases proteinase 3 and elastase in human glomerulonephritis. Am J Kidney Dis, 1995; 25: 253-61.
35. YANG JJ, KETTRITIZ R, FALK RJ, JENNETTE JC, GAIDO ML. Apoptosis of endothelial cells induced by the neutrophil serine proteases proteinase 3 elastase. Am J Pathol, 1996; 149: 1617-26.
36. REUMAUX D, VOSSEBELD PJM, ROOS D, VERHOEVEN AJ. Effect of tumor necrosis factor-induced integrin activation on Fc receptorII-mediated signal transduction relevance for activation of neutrophils by anti-proteinase 3 or anti-myeloperoxydase antibodies. Blood, 1995; 86: 3189-95.
37. MAYET WJ, CSENOK E, SZYMKOWIAK C, GROSS AWL, MEYER ZUM BÜSCHENFELDE KH. Human endothelial cells express proteinase 3, the target antigen of anticytoplasmic antibodies in Wegener's granulomatosis. Blood, 1993; 82: 1221-9.
38. JENNETTE JC, FALK RJ. Pathogenic potential of antineutrophil cytoplasmic autoantibodies. Lab Invest, 1994; 70: 135-7.
39. ESNAULT VL, TESTA A, AUDRAIN M, et al. Alpha 1-antitrypsin genetic polymorphism in ANCA-positive systemic vasculitis. Kidney Int, 1993; 43: 1329-32.
40. WITKO-SARSAT V, LESAVRE P, LOPEZ S, BESSOU G, HIEBLOT G, PRUM B, NOËL LH, GUILLEVIN L, et al. A large subset of neutrophils expressing membrane proteinase 3 is a risk factor for vasculitis and rheumatoid arthritis. J Am Soc Nephrol, 1999; 10: 1224-33.
41. HERRINGA P, BROUWER P, COHEN-TERVAERT JW, WEENING JJ, KALLENBERG CGM. Animal models of antineutrophil cytoplasmic antibody associated vasculitis. Kidney Int, 1998; 53: 253-63.
42. LESAVRE P, KINDT X, VANHILLE P, REUMAUX D, GUILLEVIN L, NOËL LH. Serial ANCA testing has limited value during the follow up of disease activity in patients with ANCA-associated vasculitis. Sarcoid Vasc Diff Lung Dis, 1996; 13: 246-8.